Manas Kanungo

VP Director Global International Commercial Marketing Strategy - Medical Device Diagnostic Biotech Therapeutic POC IVD CDx MDx - US Citizen

Manas Kanungo's Bio:

Manas Kanungo's Experience:

• Principle Adviser at IMM LLC (International Medical Marketing)

  June 2001 - Present | Irvine, Oakland and San Diego, CA

  Expertise in targeted, innovative market entry, growth, and partnership initiatives in US, Int'l and Emerging Markets including in LATAM, APAC, Brazil, India, China. - Medical Device Adviser for TalaSecure - Expert-in-Residence "EiR" @ "UCI Applied Innovation". - Coached, Mentored a start-up for Investors: A POC Burn Analyzer from Salux Diagnostics ... (ppt below). - Judge: UC Irvine Paul Merage New Venture Competition: Diagnostic, Biotechnology, Life Science - Judge: UCI Blackstone LaunchPad for a Nano-Antibiotic therapeutic solution to drug-resistant infections. - Sr Strategy Advisor for "HealthyTutor": a virtual clinical, metric based, chronic disease learning platform. - Strategic Commercial Adviser to Stem Cell, Genetic, Clinical Lab, IVD POC Rapid Diagnostic, Tele-health companies in US - Initiated an umbrella operation in Brazil for import, export, distribution, regulatory approvals. Assessed, proposed business potential w/distribution, pricing, regulatory paths. - Innovated an enhanced clinical outcomes based profitable tele-health business model in US. - Developed, implemented integrated SaaS based digital marketing, media/marcom, lead generation, CRM system for a US hospital chain. - Organized, led targeted selling, forecasting, training, clinical education for a Lab company with 50+ reps in LATAM. - Streamlined, trained, coached marketing, sales, distribution teams in Canada, LATAM for IVD / immunology / molecular diagnostic manual, automated, robotic instruments and reagents. For research institutions, laboratories, clinics, hospitals. For various cancers, genetic screening, allergies, infectious diseases, prenatal, fertility, osteoporosis. Increased sales by 10% in 1 year. - Negotiated funding with investors for a disease management based, closed loop connected platform for diabetics in emerging markets, with break-even in 2 yrs; 5 x ROI in 5 yrs.

• Sr. Director Strategic Marketing at Baebies Inc

  October 2017 - February 2019 | Morrisville, NC

  Go to http://baebies.com/resources/knowledge-center/ for details about the SEEKER and FINDER systems using Baebies' digital micro-fluidic platform with electro-wetting technology, disposable cartridges and paradigm shifting small volume, rapid and cost-effective multi-test capability with clinically relevant results in minutes vs. hours or days. Led ex-US business development for the SEEKER system - screen, evaluate, select, manage country or regional distributors and partners to create awareness for newborn screening, add Lysosomal Storage Disorders (LSDs) to private and national screening programs, and generate optimal commercial opportunities. Placed the first international systems with multi-year contract. The SEEKER is CE marked and World's First FDA Cleared system to screen newborns for Lysosomal Storage Disorders - rare metabolic diseases that if identified and treated early can significantly enhance the quality of lives for babies. Innovative technology with small footprint allows it to be up and running in half a day, easy to use by a lab technician, with results in less than 3 hours enabling same day referral for time-critical life threatening conditions. 3M+ tests have been shipped to date to screen newborns for Pompe, Gaucher, Fabry, MPS-I in the USA.... Responsible to define product use cases, specifications, test panels, and market opportunities for the FINDER near-patient mini table-top rapid analyzer with on-board plasma separation, dilution, dry-chemistry reagent mixing, and fluorescence detection... providing diagnostic quality results for up to 7 biochemical enzymatic, immunoassay or molecular tests in as little as 15 minutes from a single 50 uL fluid sample at a fraction of the cost and time compared to traditional methods.

• Dir WW Hospital & Emerging Markets, Innovation Team, Global Strategic Marketing at Abbott

  December 2009 - 2012

  Develop, manage strategic roadmaps of portfolios of products & services to meet short and long term global corporate goals for hospitals and emerging markets. Used multi-country ethnography research and NPI methods (inputs from 8 countries, over 50 hospitals, and over 500 HCPs) to identify gaps, propose prioritized business potentials, and deliver design-ready phase documents for commercial development.

• Sr. Marketing Manager Emerging Markets, Global Strategic Marketing at Bayer

  May 2004 - May 2007

  Responsible to ensure sales & profit performance; develop & implement competitive & sustainable plans for business, marketing and sales strategies, tactics, and teams; Emerging Markets Analysis for new market entries, acceleration plans, launch new products, partnerships, and investments to drive growth; Initiate, organize, and manage KOLs and a Regional Advisory Board with Medical Marketing objectives. Indirect reports w/8 region managers and internal HQ teams in a matrix organization, with about $25M Sales in Asia and Latin America.

• Director International at Quidel Corp

  August 1999 - October 2001

  Recruited to develop & grow Latin America & Canadian business, with P & L responsibility including budgeting, sales, and distribution management. Successfully increased sales 250% from $700K in 1999 to $2.5M in 2001 vs. companywide increase of 8%. Increased distributor partnerships from 8 in 5 countries to 25 in 20 countries.

• Country Business, JV & Mktg Mgr (Brazil); US Hosp Mktg Mgr, Global Strategic Mktg at Eli Lilly - Brazil JV, Roche USA, Boehringer Mannheim USA

  August 1991 - May 1999

  Selected by senior management to negotiate and manage the merger transition and transfer of the Advantage(R) Blood Glucose Monitor / Strip Diabetes business, including premature contract termination, operations, marketing, sales, inventory, and customers, from Eli Lilly to a new Patient Care Business Unit within Roche Diagnostics Brazil. ....Appointed by the Management Committee to negotiate, start up, and manage a joint venture marketing and sales operation within Eli Lilly in Brazil. Accountable for and general /operations management of annual business, operating and financial plans and goals including P&L, cash flow, ROI, pricing, budgets, marketing and sales infrastructure, product registrations, import, inventory, and logistics. ....Hired to transition the consumer based hand held Advantage(TM) glucose monitor to a hospital / laboratory based system that complied with CLIA regulations for QC/QA. Voice of the Customer in cross-functional development team....see more in resume

• Marketing Manager USA at Ohmeda (now part of GE Medical)

  June 1989 - July 1991

  Directed new product business screening and development. Managed existing product portfolio. Company develops, manufactures and markets infant warmers, incubators, scales, physiological monitors, pulse oximeters, oxygen tents, resuscitators, and phototherapy systems for the hospital neonatal intensive care units (NICU) for premature babies. Division later sold to Instrumentarium, now part of GE Medical.

• International Marketing Director at Bio-Tek Instruments Inc

  January 1984 - June 1989

  Played key role in growth of company from $2M to over $15M, with 40% of 1989 revenues coming from the Biomedical Division. Staff increased from 50 to 125. Had 2 direct, 5 indirect reports. ASTM & ISO member.

• Teaching Fellow - Biology & EE Depts at West Virginia University

  January 1982 - December 1983

  Teaching Fellow in Biology and Elect Eng Depts.

Manas Kanungo's Education:

• Stanford University

  2012 – 2012
  Continuing Studies Certificate

• UC Berkeley

  2012 – 2012
  Executive Certificate
  Concentration: High Impact Leadership

• UC Berkeley

  2012 – 2012
  Certificate
  Concentration: Bioscience, Molecular, Genomics, Proteomics, Companion Diagnostics

• UC Berkeley Haas Executive Education

  2012 – 2012
  UC Berkeley/Haas/Deloitte/Prescience BioExec Institute Certificate
  Concentration: BioPharma / Lifescience Industry Trends, Strategies, and Tactics

• UCSC

  2012 – 2012
  Continuing Education Course
  Concentration: Mobile Medical Applications

• University of California, Irvine - The Paul Merage School of Business

  2007 – 2009
  Executive MBA
  Concentration: Healthcare, Business Administration

• Thunderbird School of Global Management

  2003 – 2003
  Certificate
  Concentration: Global Leadership

• West Virginia University

  1981 – 1983
  MS
  Concentration: Biomedical Engineering, Elect Engg

• National Institute of Technology

  1972 – 1978
  BS
  Concentration: Electrical Engineering

• St. John's High School

  1965 – 1971
  Indian School Certificate
  Concentration: Science, Higher Mathematics, Biology

Manas Kanungo's Interests & Activities: